![Stuart Arbuckle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stuart Arbuckle
Director/Board Member at
RHYTHM PHARMACEUTICALS, INC.
Net worth: 31 M $ as of 2026-05-30
Profile
Mr. Stuart A. Arbuckle is an Independent Director at Rhythm Pharmaceuticals, Inc., an Independent Director at ImmunoGen, Inc. and a Chief Operating Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. He is on the Board of Directors at Rhythm Pharmaceuticals, Inc., ImmunoGen, Inc., Biotechnology Innovation Organization and Cancer Support Community. Mr. Arbuckle was previously employed as a Vice President & GM-Oncology Business Unit by Amgen, Inc. and a Principal by GlaxoSmithKline Plc. He also served on the board at Cerulean Pharma, Inc. and Wellness Community. He received his undergraduate degree from the University of Leeds.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-15 | 68,515 ( 0.03% ) | 31 M $ | 2026-05-30 | |
| 2026-04-26 | 7,000 ( 0.01% ) | 618 240 $ | 2026-05-30 | |
| 2026-04-14 | 478 ( 0% ) | 167 286 $ | 2026-05-30 |
Latest news about Stuart Arbuckle
| 25-02-10 | Vertex Pharmaceuticals Posts Higher 4Q Revenue | DJ |
Stuart Arbuckle active positions
| Companies | Position | Start |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Director/Board Member | 2019-07-23 |
| ALNYLAM PHARMACEUTICALS, INC. | Director/Board Member | 2026-01-04 |
| PRAXIS PRECISION MEDICINES, INC. | Director/Board Member | 2026-01-07 |
Cancer Support Community
 Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Director/Board Member | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | - |
Former positions of Stuart Arbuckle
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Operating Officer | 2025-06-30 |
| IMMUNOGEN, INC. | Director/Board Member | 2024-02-11 |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Director/Board Member | 2017-06-30 |
| AMGEN INC. | Corporate Officer/Principal | 2012-07-31 |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Stuart Arbuckle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellness Community
 Wellness Community Miscellaneous Commercial ServicesCommercial Services Provides professional programs of emotional support, education and hope for people impacted by cancer | Commercial Services |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides cancer support services | Commercial Services |
- Stock Market
- Insiders
- Stuart Arbuckle
